SCHEMBL17952196

SCHEMBL17952196

Cc1cc(-c2ccccc2)ccc1N1c2c(C#N)cccc2N(C)[C@@H]1C

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ TSHR P16473 1/20 0.33
▸ NOTUM Q6P988 1/20 0.32
▸ SLC6A9 P48067 1/20 0.32
▸ EGLN1 Q9GZT9 1/20 0.32
▸ AR P10275 1/20 0.32
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ NR1H2 P55055 1/20 0.31
▸ USP30 Q70CQ3 2/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ FABP5 Q01469 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17952185 0.91 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AKDM4EALDH1A1GLA
SCHEMBL17947663 0.91 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AKDM4EALDH1A1GLA
SCHEMBL17952274 0.88 ALDH1A1 (0.36) SMN1; SMN2KDM4EALDH1A1GLAGAA
SCHEMBL17952492 0.87 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AKDM4EALDH1A1GLA
SCHEMBL17952339 0.86 KDM4E (0.34) KDM4EALDH1A1GLAGAAEGLN1
SCHEMBL17952168 0.85 NPSR1 (0.33) HIF1AKDM4EALDH1A1GAATSHR
SCHEMBL17952163 0.85 TSHR (0.43) SMN1; SMN2HIF1AKDM4EALDH1A1GAA
SCHEMBL17952529 0.84 ALDH1A1 (0.37) SMN1; SMN2HIF1AKDM4EALDH1A1GLA
SCHEMBL17952318 0.84 ALDH1A1 (0.37) SMN1; SMN2KDM4EALDH1A1GLAGAA
SCHEMBL17952531 0.84 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AKDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10418569-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-17 — — US disclosed
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10418569-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OSBP2 SMN1; SMN2 3820/4885HIF1A 4782/4885KDM4E 4426/4885
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OSBP2 SMN1; SMN2 3820/4885HIF1A 4782/4885KDM4E 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback